Meropenem

Meropenem Bradex

Pharmaceutical Form
Powder for solution for injection/ infusion.
White to pale yellow crystalline powder.

 

Indications
Meropenem is indicated for the treatment of the following infections in adults and children aged 3 months and older:

 

  • Severe pneumonia, including hospital and ventilator-associated pneumonia.

  • Broncho-pulmonary infections in cystic fibrosis

  • Complicated urinary tract infections

  • Complicated intra-abdominal infections

  • Intra- and post-partum infections

  • Complicated skin and soft tissue infections

  • Acute bacterial meningiti

Product Information 
Meropenem Bradex is a broad-spectrum antibiotic belonging to the group carbapenem antibiotics.

The bactericidal effect of meropenem is exerted by inhibiting the bacterial cell wall synthesis of gram-positive and gram-negative bacteria via binding to penicillin-binding proteins (PBP).

As with other beta-lactam antibiotics, the time that meropenem concentrations exceed the minimum inhibitory concentration, MIC, (T> MIC) has been shown to correlate best with effect.

Article Number
500 mg: 419638

1 g: 057868

ATC Code 

J01DH02

For more information:

fass_edited.jpg

The page was last updated on 2020-10-02

Kontakt

Frost i Europa

  • Instagram
  • Facebook
  • Linkedin - Grå Circle

FrostPharma AB | Berga Backe 2 | 182 53 Danderyd | +46 8-24 36 60 | info@frostpharma.com